Versión en Español


Alleged Discrepancies

Article Reprints

Audio Resources

Bible Bullets

Darwin Day Debate

Decisive Designs


“In the News”

Reason & Revelation

Research Articles

Scripturally Speaking

Sensible Science


Discovery for Kids

Examine the Evidence

Home Study Courses



A.P. Information

About AP

Contact AP

Copyright Statement

Help AP

Privacy Statement

Speaking Schedules

A.P. Scientists and
Auxiliary Writers

Usage Guidelines

Apologetics Press :: Reason & Revelation
July 2002 - 1[7]:28-R

In the News: A Patent for Human Reproductive Cloning
by Brad Harrub, Ph.D.

Printer version | Email this article

April 3, 2001 came and went as just any ordinary day. This was before September 11 and the war on terrorism, so news headlines focused primarily on our prospering economy. It was not until May 16, 2002 that the Patent Watch Project discovered that on April 3, 2001 a patent had been awarded to the University of Missouri for human reproductive cloning. The patent, U.S. 6,211,429, gives the University, and Biotransplant, Inc. (a Massachusetts-based biotech company) the rights to any “products”—whether human or animal—created by the process of cloning. John F. Kilner, president of the Center for Bioethics and Human Dignity, said concerning the discovery: “The possible patenting of human beings, no matter their age, size, or stage of existence, would be a crushing blow to essential human rights and dignity. What is slavery other than one person owning another? By giving a company ownership of human beings produced through a cloning process, this patent apparently gives government approval to a new form of slavery.”

While much of the fault lies with the patent-holding researchers themselves—they quite easily could have included the word “nonhuman” before the word “mammal” in their patent application—they are not the only ones responsible for this atrocity. Money and greed play a major role as biotech companies position themselves to profit from cloning—now, and in the distant future.

Similar patent applications also are pending. For example, a group of researchers from Massachusetts has applied for a patent that allows them “to use tissues derived from NT [i.e., “nuclear transfer” (cloned)] embryos, fetuses or offspring, including human and ungulate tissues,” and to own the patent rights to the “progeny of the [cloned] offspring.” Simply put, they want to create human clones, harvest their organs, and own the rights to their children. They want to be able to use some human beings as raw materials to help others.

At the press conference where U.S. senators Specter, Kennedy, Feinstein, and Hatch first announced the release of their “pro-research cloning legislation,” Arlen Specter was asked when a cloned embryo could no longer be used morally for research. He replied: “I have not found it helpful to get into the details.” Christians, however, must “get into” the details! Human lives are at stake. And if it is this bad now, what do you imagine it will be like in the future?

Copyright © 2002 Apologetics Press, Inc. All rights reserved.

This document may be copied, on the condition that it will not be republished in print unless otherwise stated below, and will not be used for any commercial purpose, as long as the following stipulations are observed: (1) Apologetics Press must be designated as the original publisher; (2) the specific Apologetics Press Web site URL must be noted; (3) any references, footnotes, or endnotes that accompany the article must be included with any written reproduction of the article; (4) textual alterations of any kind are strictly forbidden; (5) Some illustrations (e.g., photographs, charts, graphics, etc.) are not the intellectual property of Apologetics Press and as such cannot be reproduced from our site without consent from the person or organization that maintains those intellectual rights; (6) serialization of written material (e.g., running an article in several parts) is permitted, as long as the whole of the material is made available, without editing, in a reasonable length of time; (7) articles, in whole or in part, may not be offered for sale or included in items offered for sale; and (8) articles may be reproduced in electronic form for posting on Web sites pending they are not edited or altered from their original written content and that credit is given to Apologetics Press, including the web location from which the articles were taken. Further, documents may not be copied without source statements (title, author, journal title), and the address of the publisher and owner of rights, as listed below.

For catalog, samples, or further information, contact:

Apologetics Press
230 Landmark Drive
Montgomery, Alabama 36117
Phone (334) 272-8558

Web site engine code is Copyright © 2003 by PHP-Nuke. All Rights Reserved. PHP-Nuke is Free Software released under the GNU/GPL license.
Page Generation: 0.045 Seconds